Cargando…
Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
The safety and immunological responsiveness of a peptide vaccine of ring finger protein 43 and 34-kDa translocase of the outer mitochondrial membrane combined with uracil-tegafur/leucovorin (UFT/LV) was previously demonstrated in metastatic colorectal cancer (CRC) in a phase I clinical trial. To cla...
Autores principales: | Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin-Ichi, Hazama, Shoichi, Okuno, Kiyotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835896/ https://www.ncbi.nlm.nih.gov/pubmed/29541190 http://dx.doi.org/10.3892/ol.2018.7905 |
Ejemplares similares
-
Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer
por: Kawamura, Junichiro, et al.
Publicado: (2018) -
Visualization of lymphatic flow in laparoscopic colon cancer surgery using indocyanine green fluorescence imaging
por: Ushijima, Hokuto, et al.
Publicado: (2020) -
Analysis of the clinical factors associated with anal function after intersphincteric resection for very low rectal cancer
por: Tokoro, Tadao, et al.
Publicado: (2013) -
Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008) -
Successful treatment of intractable chylous ascites after laparoscopic low anterior resection using lymphangiography and embolization with lipiodol: A case report
por: Ushijima, Hokuto, et al.
Publicado: (2021)